Logo image of UPR.I

UNIPHAR PLC (UPR.I) Stock Fundamental Analysis

DUB:UPR - Euronext Dublin - IE00BJ5FQX74 - Common Stock - Currency: EUR

3.88  0 (-0.13%)

Fundamental Rating

5

Taking everything into account, UPR scores 5 out of 10 in our fundamental rating. UPR was compared to 25 industry peers in the Health Care Providers & Services industry. UPR has an excellent profitability rating, but there are concerns on its financial health. UPR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

UPR had positive earnings in the past year.
UPR had a positive operating cash flow in the past year.
In the past 5 years UPR has always been profitable.
Each year in the past 5 years UPR had a positive operating cash flow.
UPR.I Yearly Net Income VS EBIT VS OCF VS FCFUPR.I Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

1.2 Ratios

UPR's Return On Assets of 4.53% is fine compared to the rest of the industry. UPR outperforms 80.00% of its industry peers.
UPR has a better Return On Equity (15.98%) than 84.00% of its industry peers.
UPR has a Return On Invested Capital of 9.18%. This is amongst the best in the industry. UPR outperforms 88.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for UPR is above the industry average of 5.74%.
The 3 year average ROIC (9.05%) for UPR is below the current ROIC(9.18%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.53%
ROE 15.98%
ROIC 9.18%
ROA(3y)4.04%
ROA(5y)4.1%
ROE(3y)15.06%
ROE(5y)15.61%
ROIC(3y)9.05%
ROIC(5y)8.82%
UPR.I Yearly ROA, ROE, ROICUPR.I Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

Looking at the Profit Margin, with a value of 2.32%, UPR is in line with its industry, outperforming 52.00% of the companies in the same industry.
In the last couple of years the Profit Margin of UPR has grown nicely.
UPR has a Operating Margin (3.06%) which is in line with its industry peers.
UPR's Operating Margin has improved in the last couple of years.
UPR's Gross Margin of 15.43% is on the low side compared to the rest of the industry. UPR is outperformed by 64.00% of its industry peers.
In the last couple of years the Gross Margin of UPR has grown nicely.
Industry RankSector Rank
OM 3.06%
PM (TTM) 2.32%
GM 15.43%
OM growth 3Y-0.1%
OM growth 5Y4.8%
PM growth 3Y-2.16%
PM growth 5Y12.91%
GM growth 3Y3%
GM growth 5Y7.31%
UPR.I Yearly Profit, Operating, Gross MarginsUPR.I Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so UPR is still creating some value.
The number of shares outstanding for UPR remains at a similar level compared to 1 year ago.
The number of shares outstanding for UPR remains at a similar level compared to 5 years ago.
Compared to 1 year ago, UPR has an improved debt to assets ratio.
UPR.I Yearly Shares OutstandingUPR.I Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
UPR.I Yearly Total Debt VS Total AssetsUPR.I Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

UPR has an Altman-Z score of 2.88. This is not the best score and indicates that UPR is in the grey zone with still only limited risk for bankruptcy at the moment.
UPR has a Altman-Z score of 2.88. This is in the better half of the industry: UPR outperforms 80.00% of its industry peers.
UPR has a debt to FCF ratio of 18.31. This is a negative value and a sign of low solvency as UPR would need 18.31 years to pay back of all of its debts.
With a Debt to FCF ratio value of 18.31, UPR is not doing good in the industry: 84.00% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.93 indicates that UPR is somewhat dependend on debt financing.
The Debt to Equity ratio of UPR (0.93) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 18.31
Altman-Z 2.88
ROIC/WACC1.28
WACC7.17%
UPR.I Yearly LT Debt VS Equity VS FCFUPR.I Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

UPR has a Current Ratio of 0.88. This is a bad value and indicates that UPR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.88, UPR is doing worse than 60.00% of the companies in the same industry.
A Quick Ratio of 0.56 indicates that UPR may have some problems paying its short term obligations.
UPR has a Quick ratio of 0.56. This is in the lower half of the industry: UPR underperforms 72.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.56
UPR.I Yearly Current Assets VS Current LiabilitesUPR.I Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 43.33% over the past year.
UPR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.47% yearly.
The Revenue has grown by 8.51% in the past year. This is quite good.
Measured over the past years, UPR shows a quite strong growth in Revenue. The Revenue has been growing by 10.72% on average per year.
EPS 1Y (TTM)43.33%
EPS 3Y9.69%
EPS 5Y15.47%
EPS Q2Q%13.76%
Revenue 1Y (TTM)8.51%
Revenue growth 3Y12.55%
Revenue growth 5Y10.72%
Sales Q2Q%6.8%

3.2 Future

The Earnings Per Share is expected to grow by 19.49% on average over the next years. This is quite good.
UPR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.31% yearly.
EPS Next Y10.11%
EPS Next 2Y8.96%
EPS Next 3Y9.35%
EPS Next 5Y19.49%
Revenue Next Year5.82%
Revenue Next 2Y5.42%
Revenue Next 3Y5.58%
Revenue Next 5Y2.31%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
UPR.I Yearly Revenue VS EstimatesUPR.I Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
UPR.I Yearly EPS VS EstimatesUPR.I Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.17 indicates a correct valuation of UPR.
UPR's Price/Earnings ratio is a bit cheaper when compared to the industry. UPR is cheaper than 64.00% of the companies in the same industry.
UPR is valuated rather cheaply when we compare the Price/Earnings ratio to 26.48, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 17.15 indicates a rather expensive valuation of UPR.
Based on the Price/Forward Earnings ratio, UPR is valued a bit more expensive than 64.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of UPR to the average of the S&P500 Index (34.04), we can say UPR is valued slightly cheaper.
Industry RankSector Rank
PE 16.17
Fwd PE 17.15
UPR.I Price Earnings VS Forward Price EarningsUPR.I Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of UPR indicates a slightly more expensive valuation: UPR is more expensive than 72.00% of the companies listed in the same industry.
UPR's Price/Free Cash Flow ratio is rather expensive when compared to the industry. UPR is more expensive than 88.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 45.41
EV/EBITDA 10.92
UPR.I Per share dataUPR.I EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of UPR may justify a higher PE ratio.
PEG (NY)1.6
PEG (5Y)1.05
EPS Next 2Y8.96%
EPS Next 3Y9.35%

3

5. Dividend

5.1 Amount

UPR has a yearly dividend return of 0.87%, which is pretty low.
Compared to an average industry Dividend Yield of 2.88, UPR has a dividend in line with its industry peers.
With a Dividend Yield of 0.87, UPR pays less dividend than the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 0.87%

5.2 History

The dividend of UPR is nicely growing with an annual growth rate of 33.58%!
Dividend Growth(5Y)33.58%
Div Incr Years2
Div Non Decr Years2
UPR.I Yearly Dividends per shareUPR.I Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.01 0.01 0.02 0.02 0.03

5.3 Sustainability

7.91% of the earnings are spent on dividend by UPR. This is a low number and sustainable payout ratio.
UPR's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP7.91%
EPS Next 2Y8.96%
EPS Next 3Y9.35%
UPR.I Yearly Income VS Free CF VS DividendUPR.I Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M
UPR.I Dividend Payout.UPR.I Dividend Payout, showing the Payout Ratio.UPR.I Dividend Payout.PayoutRetained Earnings

UNIPHAR PLC

DUB:UPR (8/8/2025, 7:00:00 PM)

3.88

0 (-0.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)07-29 2025-07-29
Earnings (Next)N/A N/A
Inst Owners47.75%
Inst Owner ChangeN/A
Ins Owners5.65%
Ins Owner ChangeN/A
Market Cap1.01B
Analysts81.67
Price Target4.88 (25.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.87%
Yearly Dividend0.02
Dividend Growth(5Y)33.58%
DP7.91%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.81%
PT rev (3m)5.94%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.79%
Revenue NY rev (3m)0.79%
Valuation
Industry RankSector Rank
PE 16.17
Fwd PE 17.15
P/S 0.36
P/FCF 45.41
P/OCF 8.1
P/B 2.51
P/tB N/A
EV/EBITDA 10.92
EPS(TTM)0.24
EY6.19%
EPS(NY)0.23
Fwd EY5.83%
FCF(TTM)0.09
FCFY2.2%
OCF(TTM)0.48
OCFY12.34%
SpS10.67
BVpS1.55
TBVpS-0.64
PEG (NY)1.6
PEG (5Y)1.05
Profitability
Industry RankSector Rank
ROA 4.53%
ROE 15.98%
ROCE 10.78%
ROIC 9.18%
ROICexc 10.57%
ROICexgc 62.78%
OM 3.06%
PM (TTM) 2.32%
GM 15.43%
FCFM 0.8%
ROA(3y)4.04%
ROA(5y)4.1%
ROE(3y)15.06%
ROE(5y)15.61%
ROIC(3y)9.05%
ROIC(5y)8.82%
ROICexc(3y)10.45%
ROICexc(5y)10.56%
ROICexgc(3y)82.98%
ROICexgc(5y)N/A
ROCE(3y)10.62%
ROCE(5y)10.36%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-4.71%
ROICexc growth 5Y-1.65%
OM growth 3Y-0.1%
OM growth 5Y4.8%
PM growth 3Y-2.16%
PM growth 5Y12.91%
GM growth 3Y3%
GM growth 5Y7.31%
F-Score6
Asset Turnover1.96
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 18.31
Debt/EBITDA 3.12
Cap/Depr 288.68%
Cap/Sales 3.68%
Interest Coverage 2.89
Cash Conversion 103.55%
Profit Quality 34.55%
Current Ratio 0.88
Quick Ratio 0.56
Altman-Z 2.88
F-Score6
WACC7.17%
ROIC/WACC1.28
Cap/Depr(3y)149.63%
Cap/Depr(5y)116.24%
Cap/Sales(3y)1.97%
Cap/Sales(5y)1.5%
Profit Quality(3y)72.81%
Profit Quality(5y)95.5%
High Growth Momentum
Growth
EPS 1Y (TTM)43.33%
EPS 3Y9.69%
EPS 5Y15.47%
EPS Q2Q%13.76%
EPS Next Y10.11%
EPS Next 2Y8.96%
EPS Next 3Y9.35%
EPS Next 5Y19.49%
Revenue 1Y (TTM)8.51%
Revenue growth 3Y12.55%
Revenue growth 5Y10.72%
Sales Q2Q%6.8%
Revenue Next Year5.82%
Revenue Next 2Y5.42%
Revenue Next 3Y5.58%
Revenue Next 5Y2.31%
EBIT growth 1Y9.42%
EBIT growth 3Y12.44%
EBIT growth 5Y16.03%
EBIT Next Year49.95%
EBIT Next 3Y20.25%
EBIT Next 5Y12.87%
FCF growth 1Y7.9%
FCF growth 3Y-16.24%
FCF growth 5Y-26.09%
OCF growth 1Y136.65%
OCF growth 3Y33.54%
OCF growth 5Y3.04%